At Skin Glow Dermatology , we are seeing a significant shift toward tirzepatide for three primary reasons: Clinical trials (such as the SURMOUNT series) have demonstrated that tirzepatide can achieve a 20% to 22.5% reduction in total body weight, compared with the 15% typically seen with semaglutide
It allows you to bundle your treatments into a predictable monthly plan, making it easier to budget for consistent care and achieve your long-term aesthetic goals without the stress of large, one-time payments
And unlike surgeries, theyre non-invasive, painless, and dont come with the hefty price tag or downtime
Rather, they illustrate clinical contexts in which substrate-sensitive proportionality may be more vulnerable during sustained hypophagia
B., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic, D., Madzarac, G., Rukavina, I., Sucic, M., Baric, M., Starcevic, N., Krstonijevic, Z., Bencic, M